|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2900 NOK | -1.69% |
|
-8.52% | -91.10% |
| 06-10 | Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response | CI |
| 05-15 | Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 0.399 | 1.04 | 2.12 |
| Spread/Res. | -27.32% | -72.12% | -86.32% |
| Spread/Supp. | +0.00% | +0.00% | +0.00% |
| Support | 0.29 | 0.29 | 0.29 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LIFE Stock
- Charts Lifecare ASA
Select your edition
All financial news and data tailored to specific country editions
